维普中文期刊产品整合服务
26篇 您的检索式:作者名="Bilo H"
    题名 作者 年代 出处 被引量
1Diagnosis of Hymenoptera venom allergy显示文摘Bilo BM Rueff F Mosbech H 2005Allergy2005,60,11:1
2High cumulative insulin exposure: A risk fact or of atherosclererosis in type 1 diabetes显示文摘Muis M J Bilo H J 2005Atherosclerosis2005,181,:1
3Prognosic Value of Admission Glucose and Glycoslated Hemoglobin Levels in Acute Coronary Syndromes 显示文摘Timmer J Ottervanger J Bilo H 2006QJM2006,99,4:1
4Glucose dysregulation in nondiabetic patients with ST - elevation myocardial infarction:acute and chronic glucose dysregulation in STEMI 显示文摘Rasoul S Ottervanger JP Bilo H J Timmer JR 2007Neth J Med2007,65,3:1
5Glucose dysregulation in nondiabetic patients with ST-elevation myo- cardial infarction:acute and chronic glucose dysregulation in STEMI显示文摘RASOUL S OTFERVANGER J P BILO H J 2007Neth J Med2007,65,3:1
6Glucose dysregulation in nondiabetie patients with ST-elevation myo- cardial infarction:acute and chronic glucose dysregulation in STEMI 显示文摘RASOUL S OTTERVANGER J P BILO H J 2007Neth J Med2007,65,3:1
7Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial显示文摘Susan J Logtenberg Nanne Kleefstra Sebastiaan T Houweling Klaas H Groenier Henk J Bilo 2007Journal of Hypertension2007,,1:1
8Longitudinal study on glycaemic control and quality of life in patients with type 2 diabetes mellitus referred for intensified control显示文摘Goddijn P P Bilo H J Feskens E J 1999Diabet Med1999,16,1:1
9Haemo-globin Alc:Historical overview and current concepts显示文摘Lenters-Westra E Schindhelm RK Bilo H J 2013Diabetes Res Clin Pract2013,99,2:1
10Repaglinide vs glibenclamide: a 14 - Week efficacy and saf - ety comparison 显示文摘LAUDGRAF R BILO H J G 1997Diabetes1997,46,11:1
11Prognostic value of ad mission glucose and glycosylated haemoglobin levels in acute coro- nary syndromes显示文摘Timmer JR Ottervanger JP Bilo H J 2006QJM2006,99,4:1
12Diagnosis of Hymenoptera venom allergy显示文摘Bilo BM Rueff F Mosbech H 0,,11:1
13有可植入的泵的连续 intraperitoneal 胰岛素注入的复杂并发症显示文摘 AIM: To monitor the course of continuous intraperitoneal insulin infusion (CIPII) and to gain more insight into possible complications. METHODS: A retrospective, longitudinal observational cohort study in patients with type 1 diabetes mellitus (T1DM) was performed. Only patients with 'brittle' T1DM who started CIPII between January 1, 2000 and June 1, 2011, and were treated in the only centre inThe Netherlands providing CIPII treatment (Isala clinics, Zwolle) were eligible for inclusion. Outcomes were defined as operation-free period (OFP), rate and type of complications. Subanalyses were made between patients starting CIPII from 2000 to 2007 and from 2007 onwards in order to study possible changes over time in complications and/or OFP. The OFP was calculated as the time from initial implantation to the date of first documented re-operation. If patients had not experi- enced an operation, their data were recorded at the date of last follow up or death. Kaplan-Meier curves were constructed to visualize the OFP. A (two-sided) P value of less than 0.05 was considered statistically significant. RESULTS: Fifty-seven patients were treated with CIPII, although one patient was excluded from analyses because of self-induced complications. In the remaining 56 patients, 70 complications occurred during 283 patient years. Catheter occlusion (32.9%), pump dysfunction (17.1%), pain at the pump site (15.7%) and infections (10.0%) were the most frequent complications. This resulted in a median OFP of 4.5 years (95% confidence interval 4.1-4.8 years) without any difference between the time periods. Fifty re-operations were performed because of complications, one per 5.6 patient years, with a decrease in pump dysfunction (P = 0.04) and pump explantations (P = 0.02) after 2007. In total, 9 episodes of ketoacidosis occurred during follow up and there were 69 hospital re-admissions, with a median duration of 6 d. CIPII was ceased in five patients due to recurrent infections (n = 2), pain (n = 1), inadequate glycaemic control (n = 1) or by own choice (n = 1). No CIPII related mortality was reported. CONCLUSION: The OFP has been stable over the last decade. No CIPII related mortality was reported. A significant decrease in pump dysfunction and explantation was seen after 2007 compared to the period 2000-2007. CIPII remains a safe treatment modality for specific patient groups.Peter R van Dijk Susan JJ Logtenberg Klaas H Groenier Jan Willem Haveman Nanno Kleefstra Henk JG Bilo 2012World Journal of Diabetes2012,3,8:1
14Prognostic value of troponin af- ter elective percutaneous coronary intervention : a meta-analysis 显示文摘Nienhuis MB Ottervanger JP Bilo H J 2008Catheter Cardiovasc Interv2008,71,:1
15Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis 显示文摘NIENHUIS M B OTTERVANGER J P BILO H J 2008Catheter Cardiovasc Interv2008,71,3:1
16von Willebrand factor(vWF) as a plasma marker of end othelial activation in diabetes: improved reliability with parallel determination of the vWF propeptide (vWF: AglI) 显示文摘Visher UM Emeis JJ Bilo H J 1998Thromb Haemost1998,80,6:1
17Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary synclromes显示文摘Timmer JR Ottervanger JP Bilo H J 2006QJM2006,99,:1
18Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEM1 显示文摘RASOUL S OTTERVANGER J P BILO H J 2007Neth J Med2007,65,:1
19Longitudinal study on glycaemic control and quality of life in patients with type 2 diabetes mellitus referred for intensified control 显示文摘Goddijn PP Bilo H J Feskens E J 1999Diabet Med1999,16,1:1
20The validity and reliability of the diabetes health pro? file (DHP) in DM2 patients referred for insulin therapy 显示文摘GODDIJN P BILO H MEDDOWS K 1996Qual Life Res1996,5,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费